In addition, significantly higher levels of claudin-5 have been found in patients with HT in comparison with those without HT, with a predictive cutoff value for HT of >1.601 ng/ml, sensitivity of 64.3%, and specificity of 53.9%. The gene discussed is CLDN5; the disease is hematocrit.